ReviewNeuro-oncology practice2024

Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

Amedeo A Azizi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.